CD-001

CD-001 · CD (Suzhou) Biopharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CD-001, covering 2025-02-07 to 2025-08-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, PK, and Efficacy of CD-001 in Advanced Head & Neck Cancers [Phase 1]